Webinars
QbD Approach to Small-Scale Studies to Enable Rapid Spray Drying Scale-Up
Industry experts discuss how QbD strategies can be applied in the systematic evaluation of small batches of spray-dried solid dispersions for oral delivery.
View Now
Executive Summary
Preclinical Toxicology vs Clinical: Key Considerations in Using Lipid-Based Formulations
Summary: Download this article to gain insights into the perceived barriers to developing LBFs and recent advances in translating them into useful clinical and commercial products of lipophilic drugs.
View Now
Webinars
Navigating Policy, Funding, CMC and Regulatory Dynamics for Successful Orphan Drug Development
During this webinar, industry experts will teach valuable insights, strategies, and practical knowledge to overcome the challenges and pave a successful path to orphan drug development and commercialization.
View Now
Video
Trends and Challenges in Pharmaceutical Development
Summary: Watch this video as experts discuss the complexities and opportunities for lipid-based formulations to improve drug delivery.
View Now
Webinars
HME: Debunking the Myths Around Oral Dosage Form Development Limitation
Summary: In this webinar industry experts delve into HME principles, mechanisms, and advantages over traditional methods
View Now
Webinars
Navigating Preclinical Drug Development Challenges with Lipid-Based Formulations
Summary: In this webinar experts share insights into critical considerations & strategies for dosing lipid formulations in preclinical models
View Now
Case Study
Enhancing Drug Performance Through Lipid-Based Formulations for CNS Indication
Read this case study to learn how a company engaged with Catalent to develop an oral lipid-based formulation that would lead to a more predictable and reliable drug response.
View Now
Webinars
Targeted Protein Degraders: Key strategies to Maximize VC Funding and Clinical Success
Summary: In this webinar, experts will explore the current investment and clinical landscape of Targeted Protein Degraders.
View Now
Executive Summary
Small Molecule Orphan Drugs: Status Quo, Challenges, and Perspectives
Summary: Experts explore the challenges of orphan drug development and manufacturing and will discuss how the industry is leveraging strategic partnerships to help mitigate these challenges to create a viable orphan drug business model.
View Now
Executive Summary
Targeted Protein Degraders: Through the Lens of the Innovation, Developability, and CMC Challenges
Summary: Experts review the trends and challenges associated with the rational design of targeted protein degrader drugs. In addition, experts also share perspectives on how to inform the selection and development of orally bioavailable...
View Now